{"database": "lobbying", "table": "lobbying_activities", "rows": [[1268827, "2c69d66f-3f98-40b1-9292-5bc810218a8e", "Q2", "FABIANI & COMPANY", 72576, "ZIOPHARM ONCOLOGY, INC.", 2012, "second_quarter", "MED", "Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development.", "HOUSE OF REPRESENTATIVES", 50000, null, 0, 0, "2012-07-18T11:32:26.947000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1268827"], "units": {}, "query_ms": 40.77551595401019, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}